ISKO (Shanghai) Enterprise Development Co., Ltd.
Address: Room 1212, Jiahe International Building, No. 1, Lane 66, Huayuan Road, Hongkou District, Shanghai
Company Overview
Since 1978, Esco was founded in Singapore and has become a pioneer in cleanroom technology in Southeast Asia. Esco was founded to provide high-tech clean air solutions for the high-tech and life science industries. From the beginning, Esco has gained a reputation for innovative research and development in the laboratory and cleanroom industries around the world. The Singapore headquarters leads product research, development, manufacturing and customer service. With eight offices around the world, Esco products are sold to more than 100 countries through more than 300 independent distribution partners. Esco's biological safety cabinets are the world leader, providing the industry's widest product range and instrument installation in many research institutes around the world. Esco Lifesciences Group (hereinafter referred to as "Isco Biosciences") provides supporting technologies, products and services for the life sciences and healthcare industries, supporting academic and scientific research, clinical practice, and the development and manufacturing of biopharmaceuticals. Isco Biosciences is headquartered in Singapore, with products and services covering more than 130 countries around the world, sales and service branches in more than 20 countries/regions, 8 production and R&D centers in the United States, Europe, the United Kingdom, China, Singapore, and Indonesia, and more than 1,700 employees worldwide. Today, Esco Biotech has entered the 3.0 era - with Singapore as the link between the East and the West, it is building a global life science ecosystem based on a unique multinational strategy. In May 2021, Esco Biotech completed a US$200 million Series A financing led by Vivo Capital and Novo Holdings A/S, with participation from EDBI, and also supported by internationally renowned investors including China Investment Corporation. Esco Biotech's current business divisions include Esco Scientific (hereinafter referred to as "Esco Life Sciences"), Esco Medical (hereinafter referred to as "Esco Medical") and Esco Healthcare (hereinafter referred to as "Esco Pharmaceutical Machinery"). Esco Life Sciences is a manufacturer of life science tools dedicated to providing innovative solutions for clinical, scientific research and industrial fields; Esco Medical, as a supplier of assisted reproductive technology and solutions, operates in three major regions around the world; Esco Pharmaceutical Machinery focuses on providing high-quality and customized solutions to support healthcare companies' research and transformation processes, providing the tools needed for products from the bench to the clinic - whether in clinical trials, commercial production or drug formulation. In 2020, the Jiangsu Taicang Production Center, which was invested by Isko Bio in China with an area of over 20,000 square meters, was officially put into operation, actively responding to the "Healthy China" strategy. In 2021, Isko Bio actively promoted the localization of R&D, officially established the Shanghai Zhangjiang R&D Center and the Shenzhen R&D Center, continued to increase investment in China, and deepened its presence in the Chinese market. In 2022, Isko Bio established production plants in Suzhou, Jiangsu and Taicang, Jiangsu respectively. In the same year, Shanghai Isko Pharmaceutical Technology Co., Ltd. was officially established to support the business development of Isko Pharmaceutical Machinery Division in China. Isko Bio actively responded to the "import substitution" policy. Today, all divisions under Isko Bio have basically completed their production layout in China, including Taicang Yisigao Medical Equipment Technology Co., Ltd., Isko (Suzhou) Precision Manufacturing Co., Ltd., Isko (Jiangsu) Life Science Technology Co., Ltd. and Shanghai Isko Pharmaceutical Technology Co., Ltd. Taicang Yisigao Medical Equipment Technology Co., Ltd. is mainly responsible for the production and manufacturing of life science equipment and medical equipment, providing support for the business of Yishiko Life Science and Yishiko Medical Division; Yishiko (Suzhou) Precision Manufacturing Co., Ltd. is mainly responsible for the precision processing of upstream raw materials required for equipment production, and deeply supports the group's vertical integration development; Yishiko (Jiangsu) Life Science Technology Co., Ltd. is rooted in disposable products in the biopharmaceutical field, with internationally leading product research and development capabilities and GMP-Like commercialization capabilities, serving biological cutting-edge companies including antibody drugs, new crown vaccines, cell therapy and gene therapy; Shanghai Yishiko Pharmaceutical Technology Co., Ltd. focuses on the customized development and manufacturing of pharmaceutical-specific isolator products to ensure the orderly development of the Yishiko Pharmaceutical Machinery Division's business.